Table 1.
Clinical characteristics of pancreatic cancer patients and controls
| Controls (n=18) | Patients (n=32) | P value | ||
|---|---|---|---|---|
| Gender | Male:female | 10:8 | 17:15 | 0.869 |
| Age | Years | 63 (45–77) | 64 (47–83) | 0.867 |
| WBC | (×106/ml) | 5.0 (3.6–6.8) | 5.5 (2.4–7.5) | 0.770 |
| Hb | (g/dl) | 13.0 (11.2–15.3) | 11.0 (8.5–14.6) | 0.008 |
| Cr | (mg/dl) | 0.7 (0.3–1.0) | 0.6 (0.3–1.0) | 0.238 |
| Alb | (g/dl) | 4.3 (3.8–5.0) | 3.8 (2.3–4.5) | 0.003 |
| AST | (IU/l) | 19 (16–34) | 25 (15–87) | 0.197 |
| ALT | (IU/l) | 20 (8–31) | 28 (13–237) | 0.183. |
| T.Bil | (mg/dl) | 0.5 (0.2–0.8) | 0.6 (0.3–2.8) | 0.092 |
| Amy | (IU/l) | 93 (53–176) | 59 (8–399) | 0.006 |
| CRP | (mg/dl) | 0.1 (0.0–0.6) | 0.2 (0.0–2.8) | 0.112 |
The data are expressed as median and range
WBC, white blood cells;Hb, hemoglobin; Cr, creatinine; TP, total protein; Alb albumin; AST aspirate transaminase; ALT, alanine transaminase; T.Bil total bilirubin; Amy, amylase; CRP, C reactive protein
Statistical significance was determined using the Mann–Whitney U test